The American Thyroid Association Medullary Thyroid Carcinoma Task Force, led by co-chairs Mimi I. Hu, MD and Tania Jaber, MD, has completed its work on the 2027 American Thyroid Association Guideline Update on Systemic Therapy Use in the Management of Medullary Thyroid Carcinoma.

We are now opening a 30-day review and comment period for ATA Members and Leadership. Click the links below to access the manuscript with figures and the member comment form.

Please submit your comments in the form by Sunday, November 8, for consideration by the task force prior to submission for peer review and publication in Thyroid®.

Please Note: This draft is not yet peer-reviewed and should not be distributed outside the ATA membership.

Thank you in advance for your participation and contributions to this review process. If you have any questions, please email guidelines@thyroid.org.